Pharma
NewsBY
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
NewsBY
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
